Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
exg-5003 (1 trial)
exg34217 (2 trials)
Pancytopenia (Phase 1)
Trials (3 total)
Trial APIs (2 total)